Pharmaceutics (Jun 2020)

Cationic Dendrimer G2-S16 Inhibits Herpes Simplex Type 2 Infection and Protects Mice Vaginal Microbiome

  • Carlos Guerrero-Beltrán,
  • Inmaculada Garcia-Heredia,
  • Rafael Ceña-Diez,
  • Ignacio Rodriguez-Izquierdo,
  • María Jesús Serramía,
  • Francisco Martinez-Hernandez,
  • Mónica Lluesma-Gomez,
  • Manuel Martinez-Garcia,
  • María Ángeles Muñoz-Fernández

DOI
https://doi.org/10.3390/pharmaceutics12060515
Journal volume & issue
Vol. 12, no. 6
p. 515

Abstract

Read online

The G2-S16 polyanionic carbosilane dendrimer is a promising microbicide that inhibits HSV-2 infection in vitro and in vivo in mice models. This G2-S16 dendrimer inhibits HSV-2 infection even in the presence of semen. Murine models, such as BALB/c female mice, are generally used to characterize host-pathogen interactions within the vaginal tract. However, the composition of endogenous vaginal flora remains largely undefined with modern microbiome analyses. It is important to note that the G2-S16 dendrimer does not change healthy mouse vaginal microbiome where Pseudomonas (10.2–79.1%) and Janthinobacterium (0.7–13%) are the more abundant genera. The HSV-2 vaginally infected female mice showed a significant microbiome alteration because an increase of Staphylococcus (up to 98.8%) and Escherichia (30.76%) levels were observed becoming these bacteria the predominant genera. BALB/c female mice vaginally-treated with the G2-S16 dendrimer and infected with the HSV-2 maintained a healthy vaginal microbiome similar to uninfected female mice. Summarizing, the G2-S16 polyanionic carbosilane dendrimer inhibits the HSV-2 infection in the presence of semen and prevents the alteration of mice female vaginal microbiome.

Keywords